Cargando…
Serum 3-Hydroxybutyrate is Expected to Serve as One of the Supportive Diagnostic Markers of Persistent Idiopathic Dentoalveolar Pain (PDAP)
BACKGROUND: Persistent idiopathic dentoalveolar pain (PDAP), previously referred to as atypical odontalgia, is a chronic dental pain that occurs without signs of pathology. PDAP is considered a diagnosis of exclusion, and its definition is currently under refinement and remains ambiguous. The metabo...
Autores principales: | Tamaki, Katsuya, Saito, Norihiro, Tomita, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676723/ https://www.ncbi.nlm.nih.gov/pubmed/38026450 http://dx.doi.org/10.2147/JPR.S436034 |
Ejemplares similares
-
Patients with persistent idiopathic dentoalveolar pain in dental practice
por: Sanner, Frank, et al.
Publicado: (2021) -
Treatment of Persistent Idiopathic Dentoalveolar Pain with Venlafaxine: A Multicentric Retrospective Study on Its Effectiveness and Safety
por: Xiao, Xiong, et al.
Publicado: (2023) -
Determination of Vancomycin in Human Serum by Cyclodextrin-Micellar Electrokinetic Capillary Chromatography (CD-MEKC) and Application for PDAP Patients
por: Wang, Jiajing, et al.
Publicado: (2017) -
Outcomes and Predictors of Response of Duloxetine for the Treatment of Persistent Idiopathic Dentoalveolar Pain: A Retrospective Multicenter Observational Study
por: Jia, Zipu, et al.
Publicado: (2022) -
RFX transcription factors control a miR-150/PDAP1 axis that restrains the proliferation of human T cells
por: Chirichella, Michele, et al.
Publicado: (2022)